[1]于文龙,张帆,陈定榜,等.基于德尔菲法脊柱转移瘤中医核心证候集的构建[J].中国中医骨伤科杂志,2025,33(05):56-60+68.[doi:10.20085/j.cnki.issn1005-0205.250512]
　YU Wenlong,ZHANG Fan,CHEN Dingbang,et al.Construction of Core Syndrome Set of Traditional Chinese Medicine for Spinal Metastases Based on Delphi Method[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(05):56-60+68.[doi:10.20085/j.cnki.issn1005-0205.250512]
点击复制

基于德尔菲法脊柱转移瘤中医核心证候集的构建()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年05期
页码:
56-60+68
栏目:
临床论著
出版日期:
2025-05-05

文章信息/Info

Title:
Construction of Core Syndrome Set of Traditional Chinese Medicine for Spinal Metastases Based on Delphi Method
文章编号:
1005-0205(2025)05-0056-05
作者:
于文龙1; 张帆1; 陈定榜2; 黄权2; 杨燕萍1; 马俊明1; 尹萌辰1; 2△
1上海中医药大学附属龙华医院(上海,200032); 2海军军医大学第二附属医院(上海长征医院)
Author(s):
YU Wenlong1; ZHANG Fan1; CHEN Dingbang2; HUANG Quan2; YANG Yanping1; MA Junming1; YIN Mengchen1; 2△
1Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China; 2The Second Affiliated Hospital of Naval Medical University(Shanghai Changzheng Hospital),Shanghai 200003,China.
关键词:
脊柱转移瘤;  核心证候集;  结局指标;  证候疗效评价;  德尔菲专家共识
Keywords:
spinal metastasis;  core syndrome set;  outcome index;  evaluation of syndrome effect;  Delphi expert consensus
分类号:
R738.1
DOI:
10.20085/j.cnki.issn1005-0205.250512
文献标志码:
A
摘要:
目的:构建脊柱转移瘤的中医核心证候集,为临床疗效评价提供循证依据。方法:依据COMET手册和中华中医药学会团体标准《T/CACM1339-2020中医药临床试验核心指标集研制技术规范》,采用德尔菲法形成脊柱转移瘤中医核心证候集。结果:通过对460名患者的横断面调查并结合5篇文献,构建了共4大类35个证候条目的证候条目池。最终形成了包括瘀血阻络证、气虚血瘀证、血瘀气滞证、津液亏虚证和肾精亏虚证的中医核心证候集。结论:该研究进一步完善了脊柱转移瘤中西医结合疗效评价指标体系。
Abstract:
Objective:To construct a core traditional Chinese medicine(TCM)syndrome set for spinal metastasis and provide an evidence-based foundation for clinical efficacy evaluation.Methods:Following the COMET(core outcome measures in effectiveness trials)manual and the group standard T/CACM1339-2020 established by the Chinese association of traditional Chinese medicine,the core syndromes of spine metastasis were formed by Delphi method.Results:Through a cross-sectional survey of 460 patients and combining with 5 literatures,a syndrome entry pool of 35 syndrome items in 4 categories was constructed.Finally,the core syndromes of TCM were formed,including the syndrome of blood stasis blocking collaterality,Qi deficiency and blood stasis,blood stasis and Qi stagnation,body fluid deficiency and kidney essence deficiency.Conclusion:The study further improved the evaluation index system of integrated Chinese and Western medicine for spinal metastasis.

参考文献/References:

[1] BOUTHORS C,LAUMONERIE P,CRENN V,et al.Surgical treatment of bone metastasis from osteophilic cancer:results in 401 peripheral and spinal locations[J].Orthop Traumatol Surg Res,2022,108(4):103193.
[2] 尹萌辰,刘韩森,李林,等.脊柱转移瘤预后评分系统的研究进展[J].中国脊柱脊髓杂志,2023,33(4):344-352.
[3] 于文龙,丁兴,王韬,等.脊柱转移瘤治疗决策系统的研究进展[J].脊柱外科杂志,2023,21(5):345-349.
[4] YIN M C,SUN Z W,DING X,et al.Cross-cultural adaptation and validation of simplified Chinese version of the spine oncology study group outcomes questionnaire(SOSGOQ)2.0 with its assessment in clinical setting[J].Spine Journal,2022,22(12):2024-2032.
[5] QIAO L,DING X,HE S,et al.Measurement properties of health-related quality of life measures for people living with metastatic disease of the spine:a systematic review[J].Int J Surg,2024,110(1):419-430.
[6] QIAO L,CHEN D,ZHANG F,et al.Assessing cross-cultural adaptation of the spine oncology study group outcomes questionnaire 2.0:a methodological systematic review regard to consensus-based standards for the selection of health measurement instruments guideline[J].Global Spine J,2024,14(4):1347-1355.
[7] GARGON E.The COMET(core outcome measures in effectiveness trials)initiative[J].Maturitas,2016,91:91-92.
[8] PRINSEN C A,VOHRA S,ROSE M R,et al.Core outcome measures in effectiveness trials(COMET)initiative:protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a ‘core outcome set'[J].Trials,2014,15:247.
[9] 张明妍,张俊华,张伯礼,等.中医药临床试验核心指标集研制技术规范[J].中华中医药杂志,2021,36(2):924-928.
[10] GORST S L,SEYLANOVA N,DODD S R,et al.Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition:an international Delphi consensus study[J].Lancet Respir Med,2023,11(12):1101-1114.
[11] 王雪娇,孟超,邵祯,等.基于德尔菲法筛选心肌梗死后心室重塑基本证候要素量表条目[J].中西医结合心脑血管病杂志,2023,21(18):3292-3297.
[12] 徐晓艳,郑佳乐,竺闻雷,等.肺癌脊柱转移患者中医证素及证型分布特征研究[J].中国中医骨伤科杂志,2023,31(5):18-23.
[13] 蒋林亨,郑嘉乾,周楠楠,等.中医古籍文献中骨与软组织肿瘤诊治规律的探讨[J].广州中医药大学学报,2023,40(3):755-760.
[14] 姜洋.古代中医辨证论治骨肿瘤探析[J].中国中医基础医学杂志,2018,24(10):1357-1359.
[15] EL-KARIM I,DUNCAN H F,NAGENDRABABU V,et al.The importance of establishing a core outcome set for endodontic clinical trials and outcomes studies[J].Int Endod J,2023,56(Suppl 2):200-206.
[16] MONTI M M,BEEKMAN R,SPIVAK N M,et al.Common data element for disorders of consciousness:recommendations from the working group on therapeutic interventions[J].Neurocrit Care,2024,40(1):51-57.
[17] 孙亚男,何丽云,雒琳,等.中医药治疗慢性乙型肝炎临床试验的核心结局指标集研究[J].中华中医药杂志,2020,35(9):4684-4688.
[18] 谢倩文,肖晶旻,邓雪仪,等.建立中医药治疗缺血性卒中核心结局指标集的初步研究[J].中医杂志,2022,63(3):220-228.
[19] 邱瑞瑾,孙杨,韩松洁,等.非瓣膜性房颤中医核心证候指标集的构建[J].中国循证医学杂志,2021,21(12):1480-1488.
[20] FANG G,YU W,CHEN D,et al.Development of a core outcome set of clinical research on the integration of traditional Chinese and Western medicine for spinal metastases:a study protocol[J].BMJ Open,2024,14(9):e083315.
[21] 陈江,徐翠萍,胡玉星,等.基于“阳化气,阴成形”探析脊柱肿瘤的辨治[J].中国医学创新,2024,21(11):158-162.
[22] 杨万全.基于“癌毒-气血津液”病机理论辨治肺癌经验[J].湖南中医杂志,2023,39(12):48-50.
[23] 张永健,李红专,史恒蔚,等.从虚痰瘀毒论治恶性骨肿瘤[J].中医研究,2022,35(7):5-8.
[24] 尹萌辰,王洪伸,孙正望,等.骨肉瘤中医证候要素诊断量表的构建[J].中华中医药杂志,2022,37(10):5938-5942.

备注/Memo

备注/Memo:
基金项目:上海市卫生健康委员会临床行业专项(20204Y0165,20224Y0165)
国家自然科学基金项目(82205145)
上海市“医苑新星”青年医学临床人才计划(2023-062)
中华中医药学会青年人才托举工程项目(2023-QNRC2-A03)
上海中医药大学“访名校拜名师”项目(079)
△通信作者 E-mail:yinmengchen0513@126.com
更新日期/Last Update: 2025-05-15